Page last updated: 2024-08-24

trovafloxacin and clindamycin

trovafloxacin has been researched along with clindamycin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (50.00)18.2507
2000's3 (30.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hecht, DW; Osmolski, JR1
Bradley, JS; Scheld, WM1
Maskell, JP; Rafay, AM; Sefton, AM; Whiley, A; Williams, JD1
Chuah, SK; Clark, R; Gollapudi, S; Hanna, N; Polzer, RJ; Reddy, U; Thadepalli, H1
Falagas, ME; McDermott, L; Snydman, DR1
Appelbaum, PC; Credito, KL; Ednie, LM; Jacobs, MR; Khantipong, M1

Reviews

2 review(s) available for trovafloxacin and clindamycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24 Suppl 2

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Chloramphenicol; Clindamycin; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Lactams; Male; Meningitis, Bacterial; Naphthyridines; Penicillin Resistance; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin; Virginiamycin

1997

Other Studies

8 other study(ies) available for trovafloxacin and clindamycin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23 Suppl 1

    Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Clindamycin; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Imipenem; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin

1996
The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl B

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Erythromycin; Fluoroquinolones; Gram-Positive Bacteria; Lactams; Microbial Sensitivity Tests; Naphthyridines; Vancomycin

1997
Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9

    Topics: Abdominal Abscess; Aging; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides Infections; Clindamycin; Fluoroquinolones; Male; Mice; Naphthyridines; Tissue Distribution

1997
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins

1997
Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Clindamycin; Drug Synergism; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Time Factors

2000